Clinical Management of Diffuse Low-Grade Gliomas - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cancers Année : 2020

Clinical Management of Diffuse Low-Grade Gliomas

Résumé

Diffuse low-grade gliomas (LGG) represent a heterogeneous group of primary brain tumors arising from supporting glial cells and usually affecting young adults. Advances in the knowledge of molecular profile of these tumors, including mutations in the isocitrate dehydrogenase genes, or 1p/19q codeletion, and in neuroradiological techniques have contributed to the diagnosis, prognostic stratification, and follow-up of these tumors. Optimal post-operative management of LGG is still controversial, though radiation therapy and chemotherapy remain the optimal treatments after surgical resection in selected patients. In this review, we report the most important and recent research on clinical and molecular features, new neuroradiological techniques, the different therapeutic modalities, and new opportunities for personalized targeted therapy and supportive care.
Fichier principal
Vignette du fichier
cancers-12-03008.pdf (2.36 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03009885 , version 1 (07-07-2023)

Identifiants

Citer

Giuseppe Lombardi, Valeria Barresi, Antonella Castellano, Emeline Tabouret, Francesco Pasqualetti, et al.. Clinical Management of Diffuse Low-Grade Gliomas. Cancers, 2020, 12 (10), pp.3008. ⟨10.3390/cancers12103008⟩. ⟨hal-03009885⟩
21 Consultations
4 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More